[#distribution] 🤝Genetic Analysis AS enters an agreement with @ELTA90 Group to distribute and launch GA-map® technology in the #Balkan region. ➡️ Press release: lnkd.in/daqzdjMF ⭐GA-map® - Understand the gut microbiota (ga-map.com) #diagnostics #innovation

[#interview] 🎞️Have you missed Genetic Analysis AS presentation during the Sedermera Day in Stockholm? Sedermera Corporate Finance Discover how Genetic Analysis AS is positioning itself as a key supplier of high-quality #diagnostics to the #microbiome market!🦠 ⬇️⬇️ lnkd.in/dUq6DhKK

[#event] Happy #WorldMicrobiomeDay. 🦠 At Genetic Analysis AS , we believe that the #microbiome is the new frontier of healthcare and will be a game-changer for the future of medicine. #Microbiomes4Life What do you know about The Human Microbiome? lnkd.in/dGt_8P2

[#patent]🏅Genetic Analysis AS has been awarded a patent by the South African Companies and Intellectual Property Commission (Companies and Intellectual Property Commission) 📃The patent covers GA's unique algorithm incorporated in the GA-map® technology for #profiling #gut #microbiota. ➡️ lnkd.in/dDjBtB-R

[#aacc2023] 🌍Come to booth #1147 to discover our GA-map® technology. ✅The GA-map® is a #diagnostics innovation platform for #routine #microbiota testing! ⭐Genetic Analysis AS (lnkd.in/ddD583wM), ⭐Eagle Biosciences (lnkd.in/dcTpyveQ) ⭐ga-map.com

[#publication] 🦠 New publication shows the benefits of the GA-map® testing platform in #diabetes Type 2. Collaboration with BIOASTER @BMC Endocrine Disorders; Springer Nature ➡️bmcendocrdisord.biomedcentral.com/articles/10.11… #diagnostics #innovation #Gamap #gamap #healthcare #gutmicrobiome

[#business] 🇺🇸 Genetic Analysis AS ramps up its market presence for the GA-map® microbiome testing in the US. Eagle Biosciences ➡️ Press release: news.cision.com/genetic-analys… #diagnostics #innovation #Gamap #gamap #healthcare #gutmicrobiome

[#report] 📃 Genetic Analysis AS publishes the half-year report for the second quarter and first six months of 2023 ➡️ Report: news.cision.com/genetic-analys… #diagnostics #innovation #Gamap #gamap #gastroenterology #healthcare #gutmicrobiome #investors

[#new] 📃 Stay updated and subscribe to Genetic Analysis AS investor newsletters, financial reports, and press releases ➡️Subscribe: genetic-analysis.com/stay-updated-a…

[#launch] 🦠 Unlock #microbiota insights with GA-map® Discovery! ➡️ Learn more: ga-map.com/discovery/ ➡️ Connect with us: [email protected]

[#finance] 🏛️@GeneticAnalysisAS announces the placement of directed share issue of appr. NOK 10 million. genetic-analysis.com/genetic-analys…

[#report] 📃Genetic Analysis AS AS publishes the interim report for the third quarter and the first nine months of 2023. ➡️Press release: genetic-analysis.com/interim-report… #diagnostics #innovation #Gamap #gamap #gastroenterology #healthcare #gutmicrobiome

[#event] 🦠Meet Genetic Analysis AS team during the xMAP® Connect EMEA, Amsterdam - The Netherlands, 08-09 November. Luminex "GA-map® - standardized high multiplex microbiota testing using the xMAP® Technology". 08.11, 16.05 - 16.35. info.luminexcorp.com/xmap-connect-e…

[#event] 🌍 World Diabetes Day 🌍 - 14 November 2023 The gut #microbiome has been proven to play a role in #diabetes, #obesity, #inflammation, and #metabolic diseases, among other environmental factors and genetic predispositions. lnkd.in/dcJMsBe genetic-analysis.com/new-publicatio…

[#medica2023 ] 🔬Contact, connect, and discuss standardized microbiome testing with Detlef Janke, commercial director at Genetic Analysis AS. MEDICA

[#finance]📃Genetic Analysis AS: Minutes from the Extraordinary General Meeting. Today's extraordinary general meeting formally decided on the share capital increase. ➡️Press release: genetic-analysis.com/minutes-from-t… #diagnostics #innovation #Gamap #healthcare #gutmicrobiome #investors

[#thanksgiving] 🙏Genetic Analysis AS wishes our trusted U.S. partners and collaborators (Eagle Biosciences, Doctor's Data Inc. ,among others) a moment of joy surrounded by their loved ones as well as a nice time to feel gratitude for all that is on our table. 🦃 #diagnostics #microbiota

Genetic Analysis offer of approx. NOK 9 million is ongoing. Shareholders are hereby invited to subscribe for shares with preferential right. Acquired subscription rights give the same right to subscribe for shares in the offer. The subscription period ends on December 22, 2023.

Learn more about Genetic Analysis AS on Sedermera Corporate Finance digital capital markets day on December 12, 2023, at 10:00 (CET). The event can be reached here: lnkd.in/dvrfCUbK

[#seasonsgreetings] Season’s Greetings and Happy New Year from Genetic Analysis AS Thank all our customers, distributors, and research collaborators for their support. 2024 promises to be full of exciting projects and updates that we can't wait to share with you. Stay tuned!